LAAD PLUS

Gain deep insights into patient health journeys

IQVIA’s LAAD Plus Longitudinal Access and Adjudication Data Solution gives you the information you need to make it happen.

When it comes to patient data, good enough isn’t enough!

LAAD Plus combines IQVIA's LAAD open claims database with PharMetrics® Plus closed claims database to create a comprehensive view of patient and provider actions. Watch the video!

FEATURES

The power of integrated claims data

Gain visibility into an expanded universe of medical claims, healthcare providers (HCPs), and more, providing commercial teams with accurate, repeatable, real-time insights across the entire healthcare claims continuum.

LAAD Plus results show increased patient and provider counts in key markets.

IQVIA’s Longitudinal Access and Adjudication Data Plus (LAAD Plus) solution

IQVIA delivers unmatched scale and precision by integrating open and closed claims data—empowering life sciences teams with deeper visibility into patient journeys, provider networks, and treatment dynamics.

 

* Data accumulated from 2013 through the current reporting period.

228M

Enrollees*

>400M

De-identified patients*

58B

Lifecycle claims*

>11M

Healthcare providers (HCPs)*

>752K

Healthcare organizations (HCOs)*

21B

Remittance claims*

BENEFITS

What happens when you bridge claims data gaps?

When you integrated data effectively and remove data gaps, the benefits are as clear as the journey: more effective targeting, better resource allocation, and stronger evidence for market access decisions.

Finding hidden rare disease patients in 3 weeks

Overview

When a pharma company needed to find rare disease patients, they hit a wall. Traditional claims data only showed fragments of patient stories. IQVIA's LAAD Plus changed everything by merging open and closed claims for 400+ million patients. The result? They discovered 15% more patients and providers than anyone knew existed, transforming their launch strategy in just weeks. The solution brought together LAAD's massive 300+ million patient database with PharMetrics Plus's 318-million-member records, finally filling in the missing pieces.

When a pharma company needed to find rare disease patients, they hit a wall. Traditional claims data only showed fragments of patient stories. IQVIA's LAAD Plus changed everything by merging open and closed claims for 400+ million patients. The result? They discovered 15% more patients and providers than anyone knew existed, transforming their launch strategy in just weeks. The solution brought together LAAD's massive 300+ million patient database with PharMetrics Plus's 318-million-member records, finally filling in the missing pieces.

What they found surprised everyone. There were 15% more specialists treating these rare disease patients than their original data suggested, hidden at facilities that weren't showing up before. They spotted 10% more diagnoses and 20% more procedures, suddenly seeing the full story of how patients moved through the healthcare system. Perhaps most importantly, they could finally see cash payments that had been invisible, revealing how families were paying for treatments when insurance fell short. Armed with this complete picture, the team could pinpoint exactly which doctors to approach, understand the real challenges patients faced, and build payment programs that worked. They'd found their needles in the haystack.

Challenge

Fragmented claims data obscured rare disease patients and their complete treatment journeys across providers.
Solution

LAAD Plus integrated 300M+ open claims patients with 318M closed claims enrollees for comprehensive visibility.
Results

15% more patients and providers identified, plus 20% increase in visible procedures for complete patient insights.
The integration revealed patient activity we never knew existed. We found 15% more providers treating our target population and gained visibility into treatment patterns that completely changed our market approach.
Large Pharmaceutical Company

GET IN TOUCH

Ready to elevate your patient data strategy?

Take the first step toward actionable patient data.

FACT SHEET

How can you track patients across all payers?

LAAD Plus integrates open and closed claims to reveal the complete patient journey. Access 400M+ patient records, 58B lifecycle claims, and 11M providers in one unified database. Fill critical gaps in treatment visibility and identify at-risk populations.

Read more about IQVIA Information Solutions and Services

Information Solutions Blog
Explore our blogs for expert insights into the latest Information Solutions trends and learn more about our U.S. solutions.
Insights Library
Uncover Information Solutions trends and expert insights from IQVIA thought leaders, featuring briefs, case studies, and more.

Frequently Asked Questions

LAAD Plus combines our patient-centric LAAD database (open claims) with PharMetrics® Plus (closed claims), building on IQVIA's business logic, data accuracy, and analytical methodologies. This comprehensive integration approach increases visibility across the entire claims continuum.
Closed claims provide comprehensive patient activity but are restricted by payer enrollment. Open claims offer broader coverage but may miss blocked products or specialty care. Integration eliminates these fundamental gaps for better decision-making by combining the strengths of both data types.
A recent pilot undertaken by a large pharma company identified 15% more providers and 15% more patients by integrating open and closed claims data. They also uncovered 10% more diagnoses and 20% more procedures. These documented results demonstrate the impact of comprehensive claims integration.
Yes. When you understand treatment patterns, patient flow, and real-world adherence, projections grow more reliable. This is especially valuable for rare disease and specialty segments where accurate forecasting through integrated data becomes critical for strategic planning.
LAAD Plus integrates over 400M de-identified patients, 58B lifecycle claims, and up to 11M healthcare providers across both open and closed claims datasets. This comprehensive scale and coverage ensures robust patient journey mapping across diverse therapeutic areas.
Contact Us